Effectiveness of lidocaine infusion for status epilepticus in childhood: A retrospective multi-institutional study in Japan

Hideji Hattori, Tsunekazu Yamano, Kitami Hayashi, Makiko Osawa, Kyoko Kondo, Masao Aihara, Kazuhiro Haginoya, Shinichiro Hamano, Tatsurou Izumi, Kenichiro Kaneko, Ikuko Kato, Makoto Matsukura, Kimio Minagawa, Toshio Miura, Yoko Ohtsuka, Kenji Sugai, Takao Takahashi, Hideo Yamanouchi, Hitoshi Yamamoto, Hideto Yoshikawa

研究成果: Article

22 引用 (Scopus)

抄録

We evaluated the usefulness of intravenous lidocaine therapy for managing of status epilepticus (SE) during childhood in a retrospective multi-institutional study. Questionnaires were sent to 28 hospitals concerning patients admitted for SE who were managed with lidocaine, assessing patient characteristics, treatment protocols and efficacy. In 279 treated patients, 261 SE occurrences at ages between 1 month and 15 years were analyzed. SE was classified as showing continuous, clustered, or frequently repeated seizures. Considering efficacy and side effects in combination, the usefulness of lidocaine was classified into six categories: extremely useful, useful, slightly useful, not useful, associated with deterioration, or unevaluated. In 148 SE cases (56.7%), lidocaine was rated as useful or extremely useful. Multivariate analysis indicated lidocaine was to be useful in SE with clustered and frequently repeated seizures, and SE attributable to certain acute illnesses, such as convulsions with mild gastroenteritis. Efficacy was poor when SE caused by central nervous system (CNS) infectious disease. Standard doses (approximately 2 mg/kg as a bolus, 2 mg/kg/h as maintenance) produced better outcomes than lower or higher doses. Poor responders to the initial bolus injection of lidocaine were less likely to respond to subsequent continuous infusion than good initial responders. We recommend lidocaine for use in SE with clustered or frequently repeated seizures, and in SE associated with benign infantile convulsion and convulsions with mild gastroenteritis. Lidocaine should be initiated with a bolus of 2 mg/kg. If SE is arrested by the bolus, continuous maintenance infusion should follow; treatment should proceed to different measures when SE shows a poor response to the initial bolus of lidocaine.

元の言語English
ページ(範囲)504-512
ページ数9
ジャーナルBrain and Development
30
発行部数8
DOI
出版物ステータスPublished - 2008 9
外部発表Yes

Fingerprint

Status Epilepticus
Lidocaine
Japan
Seizures
Gastroenteritis
Maintenance
Central Nervous System Diseases
Clinical Protocols
Communicable Diseases
Multivariate Analysis

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology

これを引用

Effectiveness of lidocaine infusion for status epilepticus in childhood : A retrospective multi-institutional study in Japan. / Hattori, Hideji; Yamano, Tsunekazu; Hayashi, Kitami; Osawa, Makiko; Kondo, Kyoko; Aihara, Masao; Haginoya, Kazuhiro; Hamano, Shinichiro; Izumi, Tatsurou; Kaneko, Kenichiro; Kato, Ikuko; Matsukura, Makoto; Minagawa, Kimio; Miura, Toshio; Ohtsuka, Yoko; Sugai, Kenji; Takahashi, Takao; Yamanouchi, Hideo; Yamamoto, Hitoshi; Yoshikawa, Hideto.

:: Brain and Development, 巻 30, 番号 8, 09.2008, p. 504-512.

研究成果: Article

Hattori, H, Yamano, T, Hayashi, K, Osawa, M, Kondo, K, Aihara, M, Haginoya, K, Hamano, S, Izumi, T, Kaneko, K, Kato, I, Matsukura, M, Minagawa, K, Miura, T, Ohtsuka, Y, Sugai, K, Takahashi, T, Yamanouchi, H, Yamamoto, H & Yoshikawa, H 2008, 'Effectiveness of lidocaine infusion for status epilepticus in childhood: A retrospective multi-institutional study in Japan', Brain and Development, 巻. 30, 番号 8, pp. 504-512. https://doi.org/10.1016/j.braindev.2007.12.016
Hattori, Hideji ; Yamano, Tsunekazu ; Hayashi, Kitami ; Osawa, Makiko ; Kondo, Kyoko ; Aihara, Masao ; Haginoya, Kazuhiro ; Hamano, Shinichiro ; Izumi, Tatsurou ; Kaneko, Kenichiro ; Kato, Ikuko ; Matsukura, Makoto ; Minagawa, Kimio ; Miura, Toshio ; Ohtsuka, Yoko ; Sugai, Kenji ; Takahashi, Takao ; Yamanouchi, Hideo ; Yamamoto, Hitoshi ; Yoshikawa, Hideto. / Effectiveness of lidocaine infusion for status epilepticus in childhood : A retrospective multi-institutional study in Japan. :: Brain and Development. 2008 ; 巻 30, 番号 8. pp. 504-512.
@article{32d5690eedb844bfa3d47f67fdd6e751,
title = "Effectiveness of lidocaine infusion for status epilepticus in childhood: A retrospective multi-institutional study in Japan",
abstract = "We evaluated the usefulness of intravenous lidocaine therapy for managing of status epilepticus (SE) during childhood in a retrospective multi-institutional study. Questionnaires were sent to 28 hospitals concerning patients admitted for SE who were managed with lidocaine, assessing patient characteristics, treatment protocols and efficacy. In 279 treated patients, 261 SE occurrences at ages between 1 month and 15 years were analyzed. SE was classified as showing continuous, clustered, or frequently repeated seizures. Considering efficacy and side effects in combination, the usefulness of lidocaine was classified into six categories: extremely useful, useful, slightly useful, not useful, associated with deterioration, or unevaluated. In 148 SE cases (56.7{\%}), lidocaine was rated as useful or extremely useful. Multivariate analysis indicated lidocaine was to be useful in SE with clustered and frequently repeated seizures, and SE attributable to certain acute illnesses, such as convulsions with mild gastroenteritis. Efficacy was poor when SE caused by central nervous system (CNS) infectious disease. Standard doses (approximately 2 mg/kg as a bolus, 2 mg/kg/h as maintenance) produced better outcomes than lower or higher doses. Poor responders to the initial bolus injection of lidocaine were less likely to respond to subsequent continuous infusion than good initial responders. We recommend lidocaine for use in SE with clustered or frequently repeated seizures, and in SE associated with benign infantile convulsion and convulsions with mild gastroenteritis. Lidocaine should be initiated with a bolus of 2 mg/kg. If SE is arrested by the bolus, continuous maintenance infusion should follow; treatment should proceed to different measures when SE shows a poor response to the initial bolus of lidocaine.",
keywords = "Childhood, Lidocaine, Multivariate analysis, Status epilepticus",
author = "Hideji Hattori and Tsunekazu Yamano and Kitami Hayashi and Makiko Osawa and Kyoko Kondo and Masao Aihara and Kazuhiro Haginoya and Shinichiro Hamano and Tatsurou Izumi and Kenichiro Kaneko and Ikuko Kato and Makoto Matsukura and Kimio Minagawa and Toshio Miura and Yoko Ohtsuka and Kenji Sugai and Takao Takahashi and Hideo Yamanouchi and Hitoshi Yamamoto and Hideto Yoshikawa",
year = "2008",
month = "9",
doi = "10.1016/j.braindev.2007.12.016",
language = "English",
volume = "30",
pages = "504--512",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Effectiveness of lidocaine infusion for status epilepticus in childhood

T2 - A retrospective multi-institutional study in Japan

AU - Hattori, Hideji

AU - Yamano, Tsunekazu

AU - Hayashi, Kitami

AU - Osawa, Makiko

AU - Kondo, Kyoko

AU - Aihara, Masao

AU - Haginoya, Kazuhiro

AU - Hamano, Shinichiro

AU - Izumi, Tatsurou

AU - Kaneko, Kenichiro

AU - Kato, Ikuko

AU - Matsukura, Makoto

AU - Minagawa, Kimio

AU - Miura, Toshio

AU - Ohtsuka, Yoko

AU - Sugai, Kenji

AU - Takahashi, Takao

AU - Yamanouchi, Hideo

AU - Yamamoto, Hitoshi

AU - Yoshikawa, Hideto

PY - 2008/9

Y1 - 2008/9

N2 - We evaluated the usefulness of intravenous lidocaine therapy for managing of status epilepticus (SE) during childhood in a retrospective multi-institutional study. Questionnaires were sent to 28 hospitals concerning patients admitted for SE who were managed with lidocaine, assessing patient characteristics, treatment protocols and efficacy. In 279 treated patients, 261 SE occurrences at ages between 1 month and 15 years were analyzed. SE was classified as showing continuous, clustered, or frequently repeated seizures. Considering efficacy and side effects in combination, the usefulness of lidocaine was classified into six categories: extremely useful, useful, slightly useful, not useful, associated with deterioration, or unevaluated. In 148 SE cases (56.7%), lidocaine was rated as useful or extremely useful. Multivariate analysis indicated lidocaine was to be useful in SE with clustered and frequently repeated seizures, and SE attributable to certain acute illnesses, such as convulsions with mild gastroenteritis. Efficacy was poor when SE caused by central nervous system (CNS) infectious disease. Standard doses (approximately 2 mg/kg as a bolus, 2 mg/kg/h as maintenance) produced better outcomes than lower or higher doses. Poor responders to the initial bolus injection of lidocaine were less likely to respond to subsequent continuous infusion than good initial responders. We recommend lidocaine for use in SE with clustered or frequently repeated seizures, and in SE associated with benign infantile convulsion and convulsions with mild gastroenteritis. Lidocaine should be initiated with a bolus of 2 mg/kg. If SE is arrested by the bolus, continuous maintenance infusion should follow; treatment should proceed to different measures when SE shows a poor response to the initial bolus of lidocaine.

AB - We evaluated the usefulness of intravenous lidocaine therapy for managing of status epilepticus (SE) during childhood in a retrospective multi-institutional study. Questionnaires were sent to 28 hospitals concerning patients admitted for SE who were managed with lidocaine, assessing patient characteristics, treatment protocols and efficacy. In 279 treated patients, 261 SE occurrences at ages between 1 month and 15 years were analyzed. SE was classified as showing continuous, clustered, or frequently repeated seizures. Considering efficacy and side effects in combination, the usefulness of lidocaine was classified into six categories: extremely useful, useful, slightly useful, not useful, associated with deterioration, or unevaluated. In 148 SE cases (56.7%), lidocaine was rated as useful or extremely useful. Multivariate analysis indicated lidocaine was to be useful in SE with clustered and frequently repeated seizures, and SE attributable to certain acute illnesses, such as convulsions with mild gastroenteritis. Efficacy was poor when SE caused by central nervous system (CNS) infectious disease. Standard doses (approximately 2 mg/kg as a bolus, 2 mg/kg/h as maintenance) produced better outcomes than lower or higher doses. Poor responders to the initial bolus injection of lidocaine were less likely to respond to subsequent continuous infusion than good initial responders. We recommend lidocaine for use in SE with clustered or frequently repeated seizures, and in SE associated with benign infantile convulsion and convulsions with mild gastroenteritis. Lidocaine should be initiated with a bolus of 2 mg/kg. If SE is arrested by the bolus, continuous maintenance infusion should follow; treatment should proceed to different measures when SE shows a poor response to the initial bolus of lidocaine.

KW - Childhood

KW - Lidocaine

KW - Multivariate analysis

KW - Status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=47149087609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47149087609&partnerID=8YFLogxK

U2 - 10.1016/j.braindev.2007.12.016

DO - 10.1016/j.braindev.2007.12.016

M3 - Article

C2 - 18280680

AN - SCOPUS:47149087609

VL - 30

SP - 504

EP - 512

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

IS - 8

ER -